Who owns XERIS Pharmaceuticals?

XERIS Pharmaceuticals is formerly owned by Merieux Equity Partners, through Mérieux Innovation 1, since 2017.

When did Merieux Equity Partners acquire XERIS Pharmaceuticals?

Merieux Equity Partners acquired XERIS Pharmaceuticals in 2017 and exited after 1 year.

Has XERIS Pharmaceuticals been sold?

Yes. XERIS Pharmaceuticals was exited in 2018 via IPO.

Home/Companies/Healthcare/XERIS Pharmaceuticals

XERIS Pharmaceuticals

Healthcare·

US·Exited 2018·Held 1yr

XERIS Pharmaceuticals is a healthcare company, headquartered in US.

Entry

2017

Hold

1yr

Exit

2018

Est. EV

–

Investor

Merieux Equity Partners

Key facts

HQUS

SectorHealthcare

StatusAcquired

US specialty pharmaceutical company developing ready-to-use injectable and infusion drugs.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Exit details: type, year, MOIC (buyer on Pro)

Start free

Already a member? Sign in

More from Mérieux Innovation 1

Other portfolio companies in the same fund.

Broken String Biosciences

Active

HealthcareEurope· 2023

InnoSyn

Active

HealthcareEurope· 2023

LabQuality

Active

HealthcareEurope

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated May 2026 · Sourced from public filings